Discover 2,408 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trial opportunities in Baltimore focus on areas such as oncology, dermatological conditions, neurological diseases, and gastrointestinal diseases like irritable bowel syndrome (IBS). The city’s research institutions are recruiting healthy volunteers looking for paid research opportunities or need clinical trials for a specific health condition, offering access to innovative treatments and therapies.
Filter
2
Filter results
Results: 2,408
Active & Responsive
Cognitive Task Development and Implementation for Functional MRI Studies
for
Drug Abuse, Nicotine Dependence
Location: 1 recruiting location
Sponsor: National Institute on Drug Abuse (NIDA)
Sex: All
Age: 18 - 65
Code: NCT01036685
Recruiting
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: 40 recruiting locations
Sponsor: Celgene
Sex: Male
Age: 18+
Code: NCT06764485
Phase3, Recruiting
Active & Responsive
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
for
Endometriosis, Endometrioma
Location: 1 recruiting location
Sponsor: Johns Hopkins University
Sex: Female
Age: 18 - 45
Code: NCT06847685
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
for
Alzheimer Disease, Dementia
Location: 29 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 55 - 70+
Code: NCT06721156
Phase2, Recruiting
Active & Responsive
Feasibility Study for Fibroblast Autologous Skin Grafts
for
Wounds and Injuries
Location: 1 recruiting location
Sponsor: Johns Hopkins University
Sex: All
Age: 18 - 65
Code: NCT01964859
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)